Dose intensification of chemotherapy for early breast cancer in the age of de-escalation

被引：7

作者：

Hurvitz, Sara A. ^{[1
]}

机构：

[1] Univ Calif Los Angeles, David Geffen Sch Med, Div Hematol Oncol, Santa Monica, CA 90404 USA

来源：

LANCET | 2019年 / 393卷 / 10179期

关键词：

CYCLOPHOSPHAMIDE; TRIAL;

D O I：

10.1016/S0140-6736(19)30197-7

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：1390 / 1392

页数：4

共 13 条

[1] Anthracyclines in Early Breast Cancer: The ABC Trials-USOR 06-090, NSABP B-46-I/USOR 07132, and NSABP B-49 (NRG Oncology) [J].

Blum, Joanne L. ;

Flynn, Patrick J. ;

Yothers, Greg ;

Asmar, Lina ;

Geyer, Charles E., Jr. ;

Jacobs, Samuel A. ;

Robert, Nicholas J. ;

Hopkins, Judith O. ;

O'Shaughnessy, Joyce A. ;

Dang, Chau T. ;

Gomez, Henry Leonidas ;

Fehrenbacher, Louis ;

Vukelja, Svetislava J. ;

Lyss, Alan P. ;

Paul, Devchand ;

Brufsky, Adam M. ;

Jeong, Jong-Hyeon ;

Colangelo, Linda H. ;

Swain, Sandra M. ;

Mamounas, Eleftherios P. ;

Jones, Stephen E. ;

Wolmark, Norman .

JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (23) :2647-+

[2] Increasing the dose intensity of chemotherapy by more frequent administration or sequential scheduling: a patient-level meta-analysis of 37298 women with early breast cancer in 26 randomised trials [J].

Boddington, C. ;

Bradley, R. ;

Braybrooke, J. ;

Burrett, J. ;

Clarke, M. ;

Davies, C. ;

Davies, L. ;

Dodwell, D. ;

Duane, F. ;

Evans, V. ;

Gettins, L. ;

Godwin, J. ;

Gray, R. ;

Hills, R. ;

James, S. ;

Liu, H. ;

Liu, Z. ;

MacKinnon, E. ;

Mannu, G. ;

McGale, P. ;

McHugh, T. ;

Morris, P. ;

Pan, H. ;

Peto, R. ;

Read, S. ;

Taylor, C. ;

Wang, Y. ;

Wang, Z. ;

Bradley, R. ;

Braybrooke, J. ;

Gray, R. ;

Bergh, J. ;

Peto, R. ;

Gray, Richard ;

Bradley, Rosie ;

Braybrooke, Jeremy ;

Liu, Zulian ;

Peto, Richard ;

Davies, Lucy ;

Dodwell, David ;

McGale, Paul ;

Pan, Hongchao ;

Taylor, Carolyn ;

Barlow, William ;

Bliss, Judith ;

Bruzzi, Paolo ;

Cameron, David ;

Fountzilas, George ;

Loibl, Sibylle ;

Mackey, John .

LANCET, 2019, 393 (10179) :1440-1452

[3] Cyclophosphamide, Epirubicin, and Fluorouracil Versus Dose-Dense Epirubicin and Cyclophosphamide Followed by Paclitaxel Versus Doxorubicin and Cyclophosphamide Followed by Paclitaxel in Node-Positive or High-Risk Node-Negative Breast Cancer [J].

Burnell, Margot ;

Levine, Mark N. ;

Chapman, Judith-Anne W. ;

Bramwell, Vivien ;

Gelmon, Karen ;

Walley, Barbara ;

Vandenberg, Ted ;

Chalchal, Haji ;

Albain, Kathy S. ;

Perez, Edith A. ;

Rugo, Hope ;

Pritchard, Kathleen ;

O'Brien, Patti ;

Shepherd, Lois E. .

JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (01) :77-82

[4] Randomized trial of dose-dense versus conventionally scheduled and sequential versus concurrent combination chemotherapy as postoperative adjuvant treatment of node-positive primary breast cancer: First report of intergroup trial C9741/cancer and leukemia group B trial 9741 [J].

Citron, ML ;

Berry, DA ;

Cirrincione, C ;

Hudis, C ;

Winer, EP ;

Gradishar, WJ ;

Davidson, NE ;

Martino, S ;

Livingston, R ;

Ingle, JN ;

Perez, EA ;

Carpenter, J ;

Hurd, D ;

Holland, JF ;

Smith, BL ;

Sartor, CI ;

Leung, EH ;

Abrams, J ;

Schilsky, RL ;

Muss, HB ;

Norton, L .

JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (08) :1431-1439

[5]

COLDMAN AJ, 1987, SEMIN ONCOL, V14, P29

[6] Fluorouracil and dose-dense chemotherapy in adjuvant treatment of patients with early-stage breast cancer: an open-label, 2 x 2 factorial, randomised phase 3 trial [J].

Del Mastro, Lucia y ;

De Placido, Sabino ;

Bruzzi, Paolo ;

De Laurentiis, Michele ;

Boni, Corrado ;

Cavazzini, Giovanna ;

Durando, Antonio ;

Turletti, Anna ;

Nistico, Cecilia ;

Valle, Enrichetta ;

Garrone, Ornella ;

Puglisi, Fabio ;

Montemurro, Filippo ;

Barni, Sandro ;

Ardizzoni, Andrea ;

Gamucci, Teresa ;

Colantuoni, Giuseppe ;

Giuliano, Mario ;

Gravina, Adriano ;

Papaldo, Paola ;

Bighin, Claudia ;

Bisagni, Giancarlo ;

Forestieri, Valeria ;

Cognetti, Francesco .

LANCET, 2015, 385 (9980) :1863-1872

[7] Adjuvant Cyclophosphamide and DocetaxelWith or Without Epirubicin for Early TOP2A-Normal Breast Cancer: DBCG 07-READ, an Open-Label, Phase III, Randomized Trial [J].

Ejlertsen, Bent ;

Tuxen, Malgorzata K. ;

Jakobsen, Erik Hugger ;

Jensen, Maj-Britt ;

Knoop, Ann Soegaard ;

Hojris, Inger ;

Ewertz, Marianne ;

Balslev, Eva ;

Dano, Hella ;

Vestlev, Peter Michael ;

Kenholm, Julia ;

Nielsen, Dorte L. ;

Bechmann, Troels ;

Andersson, Michael ;

Cold, Soren ;

Nielsen, Hanne Melgaard ;

Maae, Else ;

Carlsen, Dorte ;

Mouridsen, Henning T. .

JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (23) :2639-+

[8] SURGICAL ADJUVANT CHEMOTHERAPY IN CANCER OF BREAST - RESULTS OF A DECADE OF COOPERATIVE INVESTIGATION [J].

FISHER, B ;

RAVDIN, RG ;

AUSMAN, RK ;

SLACK, NH ;

MOORE, GE ;

NOER, RJ .

ANNALS OF SURGERY, 1968, 168 (03) :337-+

[9]

HARBECK N, 2017, J CLIN ONCOL S15, V35

[10] Docetaxel With Cyclophosphamide Is Associated With an Overall Survival Benefit Compared With Doxorubicin and Cyclophosphamide: 7-Year Follow-Up of US Oncology Research Trial 9735 [J].

Jones, Stephen ;

Holmes, Frankie Ann ;

O'Shaughnessy, Joyce ;

Blum, Joanne L. ;

Vukelja, Svetislava J. ;

McIntyre, Kristi J. ;

Pippen, John E. ;

Bordelon, James H. ;

Kirby, Robert L. ;

Sandbach, John ;

Hyman, William J. ;

Richards, Donald A. ;

Mennel, Robert G. ;

Boehm, Kristi A. ;

Meyer, Wally G. ;

Asmar, Lina ;

Mackey, Daniel ;

Riedel, Stefan ;

Muss, Hyman ;

Savin, Michael A. .

JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (08) :1177-1183

← 1 2 →